First Time Loading...

STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 224.82 USD -0.31% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

STERIS Plc engages in the provision of healthcare and life science product and service solutions. [ Read More ]

The intrinsic value of one STE stock under the Base Case scenario is 221.92 USD. Compared to the current market price of 224.82 USD, STERIS plc is Overvalued by 1%.

Key Points:
STE Intrinsic Value
Base Case
221.92 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
STERIS plc

Backtest STE Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling STE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

STERIS Reports Strong Q3 Performance
2024-Q3 Earnings Call

STERIS Reports Strong Q3 Performance

STERIS demonstrated a robust Q3, with a 10% surge in constant currency organic revenue stemming from increased volume and a 2.7% boost in price. Gross margin edged up by 0.5% to 43.6%, outweighing material and labor inflation as well as currency headwinds, but EBIT margin dipped by 0.8% to 23.1%. The Healthcare segment spearheaded growth, overshadowing softened demand in other divisions. A mix shift from the AST segment to Healthcare influenced the earnings landscape and is expected to persist. Net income hit $220.9 million, with capital expenditures marking $268.8 million and free cash flow reaching $457 million. Entering fiscal 2024, STERIS forecasts total revenue growth of 10-11%, with constant currency organic growth at 7-8%, and projects adjusted EPS between $8.60 and $8.70.

Financials

Balance Sheet Decomposition
STERIS plc

Current Assets 2.2B
Cash & Short-Term Investments 195.6m
Receivables 964m
Other Current Assets 1.1B
Non-Current Assets 9.2B
PP&E 2B
Intangibles 7.1B
Other Non-Current Assets 77.3m
Current Liabilities 913.7m
Accounts Payable 276.7m
Accrued Liabilities 381.1m
Other Current Liabilities 255.9m
Non-Current Liabilities 4.1B
Long-Term Debt 3.2B
Other Non-Current Liabilities 875m
Efficiency

Earnings Waterfall
STERIS plc

Revenue
5.4B USD
Cost of Revenue
-3B USD
Gross Profit
2.4B USD
Operating Expenses
-1.5B USD
Operating Income
846.9m USD
Other Expenses
-280m USD
Net Income
566.8m USD

Free Cash Flow Analysis
STERIS plc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

STE Profitability Score
Profitability Due Diligence

STERIS plc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
53/100
Profitability
Score

STERIS plc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

STE Solvency Score
Solvency Due Diligence

STERIS plc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
58/100
Solvency
Score

STERIS plc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STE Price Targets Summary
STERIS plc

Wall Street analysts forecast STE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STE is 245.24 USD with a low forecast of 217.15 USD and a high forecast of 278.25 USD.

Lowest
Price Target
217.15 USD
3% Downside
Average
Price Target
245.24 USD
9% Upside
Highest
Price Target
278.25 USD
24% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

STE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

STE Price
STERIS plc

1M 1M
-3%
6M 6M
+2%
1Y 1Y
+20%
3Y 3Y
+19%
5Y 5Y
+82%
10Y 10Y
+424%
Annual Price Range
224.82
52w Low
181.84
52w High
236.03
Price Metrics
Average Annual Return 12.93%
Standard Deviation of Annual Returns 24.2%
Max Drawdown -36%
Shares Statistics
Market Capitalization 22.2B USD
Shares Outstanding 99 354 000
Percentage of Shares Shorted 2.84%

STE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

STERIS plc Logo
STERIS plc

Country

Ireland

Industry

Health Care

Market Cap

22.2B USD

Dividend Yield

0%

Description

STERIS Plc engages in the provision of healthcare and life science product and service solutions. The firm offers a mix of consumable products, such as detergents, gastrointestinal (GI) endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair solutions, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (OR) integration. The firm operates through four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Its Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms, endoscopy suites, and renal dialysis centers.

Contact

DUBLIN
Block a Riverside IV, 70 Sir John Rogerson's Quay
+35312322000.0
https://www.steris.com/

IPO

2015-11-03

Employees

13 000

Officers

President, CEO & Director
Mr. Daniel A. Carestio
Senior VP & CFO
Mr. Michael J. Tokich
Senior VP, General Counsel & Secretary
Mr. John Adam Zangerle
SVP & Chief Human Resources Officer
Ms. Mary Clare Fraser
Senior Vice President & President of Healthcare
Mr. Cary L. Majors
Chief Accounting Officer, VP & Controller
Ms. Karen L. Burton
Show More
Vice President of Investor Relations & Corporate Communications
Julie Winter
Senior Vice President of Life Sciences
Ms. Julia K. Madsen
Senior VP & GM of Dental
Mr. Andrew Xilas
Show Less

See Also

Discover More
What is the Intrinsic Value of one STE stock?

The intrinsic value of one STE stock under the Base Case scenario is 221.92 USD.

Is STE stock undervalued or overvalued?

Compared to the current market price of 224.82 USD, STERIS plc is Overvalued by 1%.